AI models need more data about biology, and OpenAI is paying to…

MIT Technology Review reports that last year, the clinical trial policy analyst Ruxandra Teslo posted an idea for super-charging medical AI systems: use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be…

For Australian readers, the useful question is what this changes in everyday work: costs, productivity, privacy, hiring, or the tools businesses rely on. We are watching this story because practical AI adoption is moving quickly, and the impact often reaches workplaces before policy or training catches up.